CASIRIVIMAB AND IMDEVIMAB

Google image searchProduct monograph

Active ingredients

casirivimab, 1332 MG/11.1 ML

imdevimab, 1332 MG/11.1 ML

DIN: 02516705

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIALS

Schedule: COVID-19 - IO - Authorization

Company: HOFFMANN-LA ROCHE LIMITED

Date: 29-JUL-2021

ATC:

• J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
• J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
• J06BD — Antiviral monoclonal antibodies (ATC, ATC/DDD)
• J06BD07 — CASIRIVIMAB AND IMDEVIMAB (ATC/DDD)

External Links for Casirivimab And Imdevimab

Search on Google

• Casirivimab And Imdevimab side effects
• Casirivimab And Imdevimab dosage
• casirivimab side effects
• casirivimab dosage
• imdevimab side effects
• imdevimab dosage

Hoffmann-La Roche Limited

Go to Hoffmann-La Roche website to see drug product details. Sometimes you can find casirivimab and imdevimab photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.